| abstract |
The invention provides compositions comprising a humanized recombinant antibody, at least one humanized anti-EGFR antibody, at least one humanized anti-HER2 antibody, and at least one humanized anti-HER3 antibody that target the EGFR family receptors EGFR, HER2 and HER3, To the use of an antibody composition for treating cancer. The invention also relates to the use of antibodies targeting multiple EGFR-family receptors for the treatment of cancer (e. G., Pancreatic cancer) and cancer having acquired resistance to previous therapies. |